Thomas R. Staab Ii.

Companies

• TENAX THERAPEUTICS, INC.Chief financial officer May 13, 2026 to now¹
• LENSAR, Inc.Chief financial officer Sep 17, 2020 to Jun 5, 2026²
• BioCryst PharmaceuticalsChief financial officer Jul 8, 2011 to Feb 25, 2020³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• LLENSAR, Inc. LNSR174,609 shares⁴$1.0M at $5.76May 6, 2026
• TTTENAX THERAPEUTICS, INC. TENX15,675 shares⁵$23.8K at $1.52Sep 11, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Sep 11, 2026Bought 5,675 shares at $1.94 of TENAX THERAPEUTICS, INC.⁵
• May 11, 2026Granted 10,000 shares of TENAX THERAPEUTICS, INC.⁶
• May 6, 2026Shares withheld for tax 1,350 shares at $5.39 of LENSAR, Inc.⁴
• Mar 19, 2026Exercised options 5,500 shares at $2.65 of LENSAR, Inc.⁷
• Feb 18, 2026Shares withheld for tax 1,076 shares at $11.32 of LENSAR, Inc.⁸
• Jan 11, 2026Shares withheld for tax 1,826 shares at $11.57 of LENSAR, Inc.⁹
• Feb 18, 2025Granted 12,766 shares of LENSAR, Inc.¹⁰
• Jan 11, 2025Shares withheld for tax 1,839 shares at $8.25 of LENSAR, Inc.¹¹
• Aug 8, 2024Exercised options 3,500 shares at $2.65 of LENSAR, Inc.¹²
• May 6, 2024Granted 19,000 shares of LENSAR, Inc.¹³
• Jan 11, 2024Shares withheld for tax 1,853 shares at $4.43 of LENSAR, Inc.¹³
• Jan 11, 2023Granted 6,656 shares of LENSAR, Inc.¹⁴
• Dec 7, 2022Bought 727 shares at $3.16 of LENSAR, Inc.¹⁵
• Dec 6, 2022Bought 2,025 shares at $3.16 of LENSAR, Inc.¹⁵
• Jan 11, 2022Granted 15,000 shares of LENSAR, Inc.¹⁶